ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antiasthmatic Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-12R7089
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antiasthmatic Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Antiasthmatic Drug Market Research Report 2025

Code: QYRE-Auto-12R7089
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
GlaxoSmithKline PLC
ABC Farmaceutici Spa
Astrazeneca plc
Teva Pharmaceutical Industries Ltd
Mundipharma Pharmaceuticals Ltd.
MSD
Daiichi Sankyo Company Limited
Chiesi
Kyorin Pharmaceutical Co Ltd
Kissei Pharmaceutical Co Ltd
Ruiyang Pharmaceutical Co. Ltd
Fuhe Group
Lunan Pharmaceutical Group Co.Ltd.
Chengdu Huayu Pharmaceutical Co., Ltd
Kaifeng Kangnuo Pharmaceutical Co., Ltd
Akorn Pharmaceutical Co.Ltd.
Boehringer Ingelheim Pharma GmbH & Co. KG
Covis Pharmaceutical Inc.
Roche

Antiasthmatic Drug Market

The global market for Antiasthmatic Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Antiasthmatic drugs refer to the drugs that can eliminate chronic airway inflammation, relieve bronchoconstriction and spasm, dilate bronchus and reduce airway hyperresponsiveness.
North American market for Antiasthmatic Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antiasthmatic Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Antiasthmatic Drug in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Antiasthmatic Drug include Novartis AG, GlaxoSmithKline, ABC Farmaceutici Spa, AstraZeneca, Teva Pharmaceutical Industries Ltd, Mundipharma Pharmaceuticals Ltd., MSD, Daiichi Sankyo Company Limited, Chiesi GmbH, Kyorin Pharmaceutical Co.,Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Antiasthmatic Drug Market Major Factors

The Antiasthmatic Drug Market is expanding as the prevalence of asthma and respiratory disorders increases globally. Drugs such as bronchodilators, corticosteroids, and leukotriene modifiers are widely prescribed to manage symptoms and improve patient quality of life. Rising pollution, urbanization, and lifestyle factors contribute to higher asthma incidence, supporting market demand. Pharmaceutical companies continue to develop improved formulations that enhance drug delivery and patient compliance. Inhalers remain the most preferred method of administration due to convenience and efficacy. Growing awareness campaigns, healthcare access improvements, and investment in respiratory drug research further strengthen market adoption worldwide.

Antiasthmatic Drug Market Trends

Inhaled therapies are advancing with the development of smart inhalers. These devices monitor usage, track dosage adherence, and provide real-time feedback to patients and healthcare providers. Digital health integration improves disease management and treatment outcomes, making smart inhalers an important trend in asthma care.

Biologic therapies are gaining momentum as targeted treatments for severe asthma. These drugs focus on specific pathways that cause inflammation, offering improved results for patients unresponsive to conventional therapies. The growing pipeline of biologics indicates a shift toward precision medicine in asthma treatment.

Combination therapies are also expanding, with drugs that merge bronchodilators and corticosteroids into single formulations. This simplifies treatment regimens and improves patient adherence, reflecting the industry’s focus on convenience and efficiency in managing chronic conditions.

Antiasthmatic Drug Market Share

North America leads with advanced healthcare infrastructure and adoption of biologics. Europe emphasizes affordable and sustainable asthma treatment within healthcare systems. Asia-Pacific grows rapidly with high prevalence of asthma in urban areas of India and China. Latin America increases drug availability through government programs, while the Middle East and Africa strengthen awareness and access to respiratory care.

Market Segmentation

Scope of Antiasthmatic Drug Market Report

Report Metric Details
Report Name Antiasthmatic Drug Market
Segment by Type
  • Bronchodilators
  • Anti-allergic Antiasthmatic
  • Anti-inflammatory Antiasthmatic
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis AG, GlaxoSmithKline, ABC Farmaceutici Spa, AstraZeneca, Teva Pharmaceutical Industries Ltd, Mundipharma Pharmaceuticals Ltd., MSD, Daiichi Sankyo Company Limited, Chiesi GmbH, Kyorin Pharmaceutical Co.,Ltd., Kissei Pharmaceutical Co.Ltd., Ruiyang Pharmaceutical Co., Ltd, Fuhe Group, Lunan Pharmaceutical Group Co., Ltd, Chengdu Huayu Pharmaceutical Co., Ltd, Kaifeng Kangnuo Pharmaceutical Co., Ltd, Akorn Pharmaceutical Co.Ltd., Boehringer Ingelheim Pharma GmbH&Co.KG, Covis Pharmaceutical Inc, Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antiasthmatic Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antiasthmatic Drug Market report?

Ans: The main players in the Antiasthmatic Drug Market are Novartis AG, GlaxoSmithKline, ABC Farmaceutici Spa, AstraZeneca, Teva Pharmaceutical Industries Ltd, Mundipharma Pharmaceuticals Ltd., MSD, Daiichi Sankyo Company Limited, Chiesi GmbH, Kyorin Pharmaceutical Co.,Ltd., Kissei Pharmaceutical Co.Ltd., Ruiyang Pharmaceutical Co., Ltd, Fuhe Group, Lunan Pharmaceutical Group Co., Ltd, Chengdu Huayu Pharmaceutical Co., Ltd, Kaifeng Kangnuo Pharmaceutical Co., Ltd, Akorn Pharmaceutical Co.Ltd., Boehringer Ingelheim Pharma GmbH&Co.KG, Covis Pharmaceutical Inc, Roche

What are the Application segmentation covered in the Antiasthmatic Drug Market report?

Ans: The Applications covered in the Antiasthmatic Drug Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Antiasthmatic Drug Market report?

Ans: The Types covered in the Antiasthmatic Drug Market report are Bronchodilators, Anti-allergic Antiasthmatic, Anti-inflammatory Antiasthmatic

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiasthmatic Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bronchodilators
1.2.3 Anti-allergic Antiasthmatic
1.2.4 Anti-inflammatory Antiasthmatic
1.3 Market by Application
1.3.1 Global Antiasthmatic Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiasthmatic Drug Market Perspective (2020-2031)
2.2 Global Antiasthmatic Drug Growth Trends by Region
2.2.1 Global Antiasthmatic Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antiasthmatic Drug Historic Market Size by Region (2020-2025)
2.2.3 Antiasthmatic Drug Forecasted Market Size by Region (2026-2031)
2.3 Antiasthmatic Drug Market Dynamics
2.3.1 Antiasthmatic Drug Industry Trends
2.3.2 Antiasthmatic Drug Market Drivers
2.3.3 Antiasthmatic Drug Market Challenges
2.3.4 Antiasthmatic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiasthmatic Drug Players by Revenue
3.1.1 Global Top Antiasthmatic Drug Players by Revenue (2020-2025)
3.1.2 Global Antiasthmatic Drug Revenue Market Share by Players (2020-2025)
3.2 Global Antiasthmatic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antiasthmatic Drug Revenue
3.4 Global Antiasthmatic Drug Market Concentration Ratio
3.4.1 Global Antiasthmatic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiasthmatic Drug Revenue in 2024
3.5 Global Key Players of Antiasthmatic Drug Head office and Area Served
3.6 Global Key Players of Antiasthmatic Drug, Product and Application
3.7 Global Key Players of Antiasthmatic Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiasthmatic Drug Breakdown Data by Type
4.1 Global Antiasthmatic Drug Historic Market Size by Type (2020-2025)
4.2 Global Antiasthmatic Drug Forecasted Market Size by Type (2026-2031)
5 Antiasthmatic Drug Breakdown Data by Application
5.1 Global Antiasthmatic Drug Historic Market Size by Application (2020-2025)
5.2 Global Antiasthmatic Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antiasthmatic Drug Market Size (2020-2031)
6.2 North America Antiasthmatic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antiasthmatic Drug Market Size by Country (2020-2025)
6.4 North America Antiasthmatic Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiasthmatic Drug Market Size (2020-2031)
7.2 Europe Antiasthmatic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antiasthmatic Drug Market Size by Country (2020-2025)
7.4 Europe Antiasthmatic Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiasthmatic Drug Market Size (2020-2031)
8.2 Asia-Pacific Antiasthmatic Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antiasthmatic Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Antiasthmatic Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiasthmatic Drug Market Size (2020-2031)
9.2 Latin America Antiasthmatic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antiasthmatic Drug Market Size by Country (2020-2025)
9.4 Latin America Antiasthmatic Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiasthmatic Drug Market Size (2020-2031)
10.2 Middle East & Africa Antiasthmatic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antiasthmatic Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Antiasthmatic Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Antiasthmatic Drug Introduction
11.1.4 Novartis AG Revenue in Antiasthmatic Drug Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Antiasthmatic Drug Introduction
11.2.4 GlaxoSmithKline Revenue in Antiasthmatic Drug Business (2020-2025)
11.2.5 GlaxoSmithKline Recent Development
11.3 ABC Farmaceutici Spa
11.3.1 ABC Farmaceutici Spa Company Details
11.3.2 ABC Farmaceutici Spa Business Overview
11.3.3 ABC Farmaceutici Spa Antiasthmatic Drug Introduction
11.3.4 ABC Farmaceutici Spa Revenue in Antiasthmatic Drug Business (2020-2025)
11.3.5 ABC Farmaceutici Spa Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Antiasthmatic Drug Introduction
11.4.4 AstraZeneca Revenue in Antiasthmatic Drug Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 Teva Pharmaceutical Industries Ltd
11.5.1 Teva Pharmaceutical Industries Ltd Company Details
11.5.2 Teva Pharmaceutical Industries Ltd Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Introduction
11.5.4 Teva Pharmaceutical Industries Ltd Revenue in Antiasthmatic Drug Business (2020-2025)
11.5.5 Teva Pharmaceutical Industries Ltd Recent Development
11.6 Mundipharma Pharmaceuticals Ltd.
11.6.1 Mundipharma Pharmaceuticals Ltd. Company Details
11.6.2 Mundipharma Pharmaceuticals Ltd. Business Overview
11.6.3 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Introduction
11.6.4 Mundipharma Pharmaceuticals Ltd. Revenue in Antiasthmatic Drug Business (2020-2025)
11.6.5 Mundipharma Pharmaceuticals Ltd. Recent Development
11.7 MSD
11.7.1 MSD Company Details
11.7.2 MSD Business Overview
11.7.3 MSD Antiasthmatic Drug Introduction
11.7.4 MSD Revenue in Antiasthmatic Drug Business (2020-2025)
11.7.5 MSD Recent Development
11.8 Daiichi Sankyo Company Limited
11.8.1 Daiichi Sankyo Company Limited Company Details
11.8.2 Daiichi Sankyo Company Limited Business Overview
11.8.3 Daiichi Sankyo Company Limited Antiasthmatic Drug Introduction
11.8.4 Daiichi Sankyo Company Limited Revenue in Antiasthmatic Drug Business (2020-2025)
11.8.5 Daiichi Sankyo Company Limited Recent Development
11.9 Chiesi GmbH
11.9.1 Chiesi GmbH Company Details
11.9.2 Chiesi GmbH Business Overview
11.9.3 Chiesi GmbH Antiasthmatic Drug Introduction
11.9.4 Chiesi GmbH Revenue in Antiasthmatic Drug Business (2020-2025)
11.9.5 Chiesi GmbH Recent Development
11.10 Kyorin Pharmaceutical Co.,Ltd.
11.10.1 Kyorin Pharmaceutical Co.,Ltd. Company Details
11.10.2 Kyorin Pharmaceutical Co.,Ltd. Business Overview
11.10.3 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Introduction
11.10.4 Kyorin Pharmaceutical Co.,Ltd. Revenue in Antiasthmatic Drug Business (2020-2025)
11.10.5 Kyorin Pharmaceutical Co.,Ltd. Recent Development
11.11 Kissei Pharmaceutical Co.Ltd.
11.11.1 Kissei Pharmaceutical Co.Ltd. Company Details
11.11.2 Kissei Pharmaceutical Co.Ltd. Business Overview
11.11.3 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Introduction
11.11.4 Kissei Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2020-2025)
11.11.5 Kissei Pharmaceutical Co.Ltd. Recent Development
11.12 Ruiyang Pharmaceutical Co., Ltd
11.12.1 Ruiyang Pharmaceutical Co., Ltd Company Details
11.12.2 Ruiyang Pharmaceutical Co., Ltd Business Overview
11.12.3 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.12.4 Ruiyang Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2020-2025)
11.12.5 Ruiyang Pharmaceutical Co., Ltd Recent Development
11.13 Fuhe Group
11.13.1 Fuhe Group Company Details
11.13.2 Fuhe Group Business Overview
11.13.3 Fuhe Group Antiasthmatic Drug Introduction
11.13.4 Fuhe Group Revenue in Antiasthmatic Drug Business (2020-2025)
11.13.5 Fuhe Group Recent Development
11.14 Lunan Pharmaceutical Group Co., Ltd
11.14.1 Lunan Pharmaceutical Group Co., Ltd Company Details
11.14.2 Lunan Pharmaceutical Group Co., Ltd Business Overview
11.14.3 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Introduction
11.14.4 Lunan Pharmaceutical Group Co., Ltd Revenue in Antiasthmatic Drug Business (2020-2025)
11.14.5 Lunan Pharmaceutical Group Co., Ltd Recent Development
11.15 Chengdu Huayu Pharmaceutical Co., Ltd
11.15.1 Chengdu Huayu Pharmaceutical Co., Ltd Company Details
11.15.2 Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
11.15.3 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.15.4 Chengdu Huayu Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2020-2025)
11.15.5 Chengdu Huayu Pharmaceutical Co., Ltd Recent Development
11.16 Kaifeng Kangnuo Pharmaceutical Co., Ltd
11.16.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Details
11.16.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
11.16.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.16.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2020-2025)
11.16.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Development
11.17 Akorn Pharmaceutical Co.Ltd.
11.17.1 Akorn Pharmaceutical Co.Ltd. Company Details
11.17.2 Akorn Pharmaceutical Co.Ltd. Business Overview
11.17.3 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Introduction
11.17.4 Akorn Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2020-2025)
11.17.5 Akorn Pharmaceutical Co.Ltd. Recent Development
11.18 Boehringer Ingelheim Pharma GmbH&Co.KG
11.18.1 Boehringer Ingelheim Pharma GmbH&Co.KG Company Details
11.18.2 Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
11.18.3 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Introduction
11.18.4 Boehringer Ingelheim Pharma GmbH&Co.KG Revenue in Antiasthmatic Drug Business (2020-2025)
11.18.5 Boehringer Ingelheim Pharma GmbH&Co.KG Recent Development
11.19 Covis Pharmaceutical Inc
11.19.1 Covis Pharmaceutical Inc Company Details
11.19.2 Covis Pharmaceutical Inc Business Overview
11.19.3 Covis Pharmaceutical Inc Antiasthmatic Drug Introduction
11.19.4 Covis Pharmaceutical Inc Revenue in Antiasthmatic Drug Business (2020-2025)
11.19.5 Covis Pharmaceutical Inc Recent Development
11.20 Roche
11.20.1 Roche Company Details
11.20.2 Roche Business Overview
11.20.3 Roche Antiasthmatic Drug Introduction
11.20.4 Roche Revenue in Antiasthmatic Drug Business (2020-2025)
11.20.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis
GlaxoSmithKline PLC
ABC Farmaceutici Spa
Astrazeneca plc
Teva Pharmaceutical Industries Ltd
Mundipharma Pharmaceuticals Ltd.
MSD
Daiichi Sankyo Company Limited
Chiesi
Kyorin Pharmaceutical Co Ltd
Kissei Pharmaceutical Co Ltd
Ruiyang Pharmaceutical Co. Ltd
Fuhe Group
Lunan Pharmaceutical Group Co.Ltd.
Chengdu Huayu Pharmaceutical Co., Ltd
Kaifeng Kangnuo Pharmaceutical Co., Ltd
Akorn Pharmaceutical Co.Ltd.
Boehringer Ingelheim Pharma GmbH & Co. KG
Covis Pharmaceutical Inc.
Roche
List of Tables
 Table 1. Global Antiasthmatic Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Bronchodilators
 Table 3. Key Players of Anti-allergic Antiasthmatic
 Table 4. Key Players of Anti-inflammatory Antiasthmatic
 Table 5. Global Antiasthmatic Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Antiasthmatic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Antiasthmatic Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Antiasthmatic Drug Market Share by Region (2020-2025)
 Table 9. Global Antiasthmatic Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Antiasthmatic Drug Market Share by Region (2026-2031)
 Table 11. Antiasthmatic Drug Market Trends
 Table 12. Antiasthmatic Drug Market Drivers
 Table 13. Antiasthmatic Drug Market Challenges
 Table 14. Antiasthmatic Drug Market Restraints
 Table 15. Global Antiasthmatic Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Antiasthmatic Drug Market Share by Players (2020-2025)
 Table 17. Global Top Antiasthmatic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiasthmatic Drug as of 2024)
 Table 18. Ranking of Global Top Antiasthmatic Drug Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Antiasthmatic Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Antiasthmatic Drug, Headquarters and Area Served
 Table 21. Global Key Players of Antiasthmatic Drug, Product and Application
 Table 22. Global Key Players of Antiasthmatic Drug, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Antiasthmatic Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Antiasthmatic Drug Revenue Market Share by Type (2020-2025)
 Table 26. Global Antiasthmatic Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Antiasthmatic Drug Revenue Market Share by Type (2026-2031)
 Table 28. Global Antiasthmatic Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Antiasthmatic Drug Revenue Market Share by Application (2020-2025)
 Table 30. Global Antiasthmatic Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Antiasthmatic Drug Revenue Market Share by Application (2026-2031)
 Table 32. North America Antiasthmatic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Antiasthmatic Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Antiasthmatic Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Antiasthmatic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Antiasthmatic Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Antiasthmatic Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Antiasthmatic Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Antiasthmatic Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Antiasthmatic Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Antiasthmatic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Antiasthmatic Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Antiasthmatic Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Antiasthmatic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Antiasthmatic Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Antiasthmatic Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Novartis AG Company Details
 Table 48. Novartis AG Business Overview
 Table 49. Novartis AG Antiasthmatic Drug Product
 Table 50. Novartis AG Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 51. Novartis AG Recent Development
 Table 52. GlaxoSmithKline Company Details
 Table 53. GlaxoSmithKline Business Overview
 Table 54. GlaxoSmithKline Antiasthmatic Drug Product
 Table 55. GlaxoSmithKline Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 56. GlaxoSmithKline Recent Development
 Table 57. ABC Farmaceutici Spa Company Details
 Table 58. ABC Farmaceutici Spa Business Overview
 Table 59. ABC Farmaceutici Spa Antiasthmatic Drug Product
 Table 60. ABC Farmaceutici Spa Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 61. ABC Farmaceutici Spa Recent Development
 Table 62. AstraZeneca Company Details
 Table 63. AstraZeneca Business Overview
 Table 64. AstraZeneca Antiasthmatic Drug Product
 Table 65. AstraZeneca Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 66. AstraZeneca Recent Development
 Table 67. Teva Pharmaceutical Industries Ltd Company Details
 Table 68. Teva Pharmaceutical Industries Ltd Business Overview
 Table 69. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product
 Table 70. Teva Pharmaceutical Industries Ltd Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 71. Teva Pharmaceutical Industries Ltd Recent Development
 Table 72. Mundipharma Pharmaceuticals Ltd. Company Details
 Table 73. Mundipharma Pharmaceuticals Ltd. Business Overview
 Table 74. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product
 Table 75. Mundipharma Pharmaceuticals Ltd. Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 76. Mundipharma Pharmaceuticals Ltd. Recent Development
 Table 77. MSD Company Details
 Table 78. MSD Business Overview
 Table 79. MSD Antiasthmatic Drug Product
 Table 80. MSD Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 81. MSD Recent Development
 Table 82. Daiichi Sankyo Company Limited Company Details
 Table 83. Daiichi Sankyo Company Limited Business Overview
 Table 84. Daiichi Sankyo Company Limited Antiasthmatic Drug Product
 Table 85. Daiichi Sankyo Company Limited Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 86. Daiichi Sankyo Company Limited Recent Development
 Table 87. Chiesi GmbH Company Details
 Table 88. Chiesi GmbH Business Overview
 Table 89. Chiesi GmbH Antiasthmatic Drug Product
 Table 90. Chiesi GmbH Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 91. Chiesi GmbH Recent Development
 Table 92. Kyorin Pharmaceutical Co.,Ltd. Company Details
 Table 93. Kyorin Pharmaceutical Co.,Ltd. Business Overview
 Table 94. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product
 Table 95. Kyorin Pharmaceutical Co.,Ltd. Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 96. Kyorin Pharmaceutical Co.,Ltd. Recent Development
 Table 97. Kissei Pharmaceutical Co.Ltd. Company Details
 Table 98. Kissei Pharmaceutical Co.Ltd. Business Overview
 Table 99. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product
 Table 100. Kissei Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 101. Kissei Pharmaceutical Co.Ltd. Recent Development
 Table 102. Ruiyang Pharmaceutical Co., Ltd Company Details
 Table 103. Ruiyang Pharmaceutical Co., Ltd Business Overview
 Table 104. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product
 Table 105. Ruiyang Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 106. Ruiyang Pharmaceutical Co., Ltd Recent Development
 Table 107. Fuhe Group Company Details
 Table 108. Fuhe Group Business Overview
 Table 109. Fuhe Group Antiasthmatic Drug Product
 Table 110. Fuhe Group Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 111. Fuhe Group Recent Development
 Table 112. Lunan Pharmaceutical Group Co., Ltd Company Details
 Table 113. Lunan Pharmaceutical Group Co., Ltd Business Overview
 Table 114. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product
 Table 115. Lunan Pharmaceutical Group Co., Ltd Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 116. Lunan Pharmaceutical Group Co., Ltd Recent Development
 Table 117. Chengdu Huayu Pharmaceutical Co., Ltd Company Details
 Table 118. Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
 Table 119. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product
 Table 120. Chengdu Huayu Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 121. Chengdu Huayu Pharmaceutical Co., Ltd Recent Development
 Table 122. Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Details
 Table 123. Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
 Table 124. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product
 Table 125. Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 126. Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Development
 Table 127. Akorn Pharmaceutical Co.Ltd. Company Details
 Table 128. Akorn Pharmaceutical Co.Ltd. Business Overview
 Table 129. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product
 Table 130. Akorn Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 131. Akorn Pharmaceutical Co.Ltd. Recent Development
 Table 132. Boehringer Ingelheim Pharma GmbH&Co.KG Company Details
 Table 133. Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
 Table 134. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product
 Table 135. Boehringer Ingelheim Pharma GmbH&Co.KG Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 136. Boehringer Ingelheim Pharma GmbH&Co.KG Recent Development
 Table 137. Covis Pharmaceutical Inc Company Details
 Table 138. Covis Pharmaceutical Inc Business Overview
 Table 139. Covis Pharmaceutical Inc Antiasthmatic Drug Product
 Table 140. Covis Pharmaceutical Inc Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 141. Covis Pharmaceutical Inc Recent Development
 Table 142. Roche Company Details
 Table 143. Roche Business Overview
 Table 144. Roche Antiasthmatic Drug Product
 Table 145. Roche Revenue in Antiasthmatic Drug Business (2020-2025) & (US$ Million)
 Table 146. Roche Recent Development
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. Authors List of This Report


List of Figures
 Figure 1. Antiasthmatic Drug Picture
 Figure 2. Global Antiasthmatic Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antiasthmatic Drug Market Share by Type: 2024 VS 2031
 Figure 4. Bronchodilators Features
 Figure 5. Anti-allergic Antiasthmatic Features
 Figure 6. Anti-inflammatory Antiasthmatic Features
 Figure 7. Global Antiasthmatic Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Antiasthmatic Drug Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Clinic Case Studies
 Figure 11. Other Case Studies
 Figure 12. Antiasthmatic Drug Report Years Considered
 Figure 13. Global Antiasthmatic Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Antiasthmatic Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Antiasthmatic Drug Market Share by Region: 2024 VS 2031
 Figure 16. Global Antiasthmatic Drug Market Share by Players in 2024
 Figure 17. Global Top Antiasthmatic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiasthmatic Drug as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Antiasthmatic Drug Revenue in 2024
 Figure 19. North America Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Antiasthmatic Drug Market Share by Country (2020-2031)
 Figure 21. United States Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Antiasthmatic Drug Market Share by Country (2020-2031)
 Figure 25. Germany Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Antiasthmatic Drug Market Share by Region (2020-2031)
 Figure 33. China Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Antiasthmatic Drug Market Share by Country (2020-2031)
 Figure 41. Mexico Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Antiasthmatic Drug Market Share by Country (2020-2031)
 Figure 45. Turkey Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Antiasthmatic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Novartis AG Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 49. GlaxoSmithKline Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 50. ABC Farmaceutici Spa Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 51. AstraZeneca Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 52. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 53. Mundipharma Pharmaceuticals Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 54. MSD Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 55. Daiichi Sankyo Company Limited Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 56. Chiesi GmbH Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 57. Kyorin Pharmaceutical Co.,Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 58. Kissei Pharmaceutical Co.Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 59. Ruiyang Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 60. Fuhe Group Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 61. Lunan Pharmaceutical Group Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 62. Chengdu Huayu Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 63. Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 64. Akorn Pharmaceutical Co.Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 65. Boehringer Ingelheim Pharma GmbH&Co.KG Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 66. Covis Pharmaceutical Inc Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 67. Roche Revenue Growth Rate in Antiasthmatic Drug Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Anti Asthmatics and COPD Drugs Market Research Report 2024
Antitussive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Allergy Medicine Market Research Report 2024
Anti Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bronchial Spasm Treatment Market Research Report 2024
Antispasmodics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiallergics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Allergic Asthma Therapeutics Market Research Report 2025
Global Asthma Therapeutic Drug Market Research Report 2024
Global Asthma Medication Market Research Report 2025
Antispasmodics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Mite Drugs Market Research Report 2024
Antiglaucoma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antihistamine Medications Market Research Report 2025
Global Cat Allergy Medicine Market Research Report 2024
Global Bronchitis Drug Market Research Report 2024
Global Acute Bronchitis Treatment Drug Market Research Report 2025
Global Asthma Therapeutics Market Research Report 2025
Global Asthma Clinical Therapeutic Drug Market Research Report 2025
Global Anticholinergics and Antispasmodics Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions